Medtech Insights

The Latin American market for urological devices will experience modest growth through 2027, driven primarily by the aging population, greater access to health care across the region, increased…

New treatment and screening guidelines, as well as the introduction of less invasive screening technologies will support growth in several GI endoscopy device segments. However, continued hospital…

The Asia Pacific market for laparoscopic devices will grow moderately during the forecast period. The emerging markets will be driven primarily by rising procedure volumes, while revenue growth…

The US varicose vein treatment device market will be characterized by modest growth and a changing reimbursement landscape for new endovenous ablation technologies, which will compete with more…

The North American dental implant market continues to expand robustly, supported by growing patient awareness of dental implant treatments that is spurred by increased marketing efforts by DSOs…

The Japanese urological device market will grow steadily through 2027, largely due to the growing elderly population and the preference for premium technology. However, many facilities already…

Although budget constraints on health care facilities continue to create downward pricing pressures, the European laparoscopic device market will grow modestly overall through 2027, driven by the…

The US laparoscopic device market will grow modestly through 2027, fueled by laparoscopic procedure volume growth, demand for robotic-assisted surgery, the launch of new and innovative products,…

The Asia Pacific urological device market will continue to expand through 2027 due to growing patient awareness of urological treatments in this region. In particular, rising use of minimally…

The Latin American market for gynecological devices will be driven by increased patient awareness and physician preference for noninvasive techniques. However, the poor economic conditions and…

The European interventional oncology device market will be characterized by procedure volume growth, spurred by enhanced reimbursement, product improvements, and the availability of new…

The Asia Pacific market for interventional oncology will expand through 2027, driven primarily by continued growth of cancer incidence, improving access to treatment, and the entry of new…